Yuvezzi Solution/ Drops
Product Images NDC 84892-275

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Yuvezzi (NDC 84892-275). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Visus Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Yuvezzi 01)

Chemical structure diagram showing a molecule with an amide group (NH2 and C=O) linked to a positively charged nitrogen with three methyl groups, and a chloride ion (Cl-). This likely represents a component or related structure to the active ingredients carbachol and brimonidine tartrate in YUVEZZI ophthalmic solution/drops.*

FDA Label Image

Chemical Structure (Yuvezzi 02)

Chemical structure diagrams of the active ingredients carbachol and brimonidine tartrate. The image shows the molecular formulas representing their chemical composition and bonding.*

FDA Label Image

Principal Display Panel (0.16 mL Vial Pouch Carton)

Packaging label for YUVEZZI ophthalmic solution containing carbachol and brimonidine tartrate at 2.75% and 0.1%. Label shows Rx only, intended for topical ophthalmic use, with package containing 6 pouches of 5 single-dose vials (0.16 mL each). Labeler is Visus Therapeutics, Inc., with barcode and storage instructions included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.